| [1] |
.
Guidelines for the diagnosis and treatment of superficial lymph node tuberculosis with integrated traditional Chinese and Western medicine
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 429-447.
|
| [2] |
Ji Lianrong, Xue Yunlian, Jiang Xue, Yuan Shasha, Liu Guihao, Wang Xiaowan, Zou Xia, Wang Tingting, Zhou Zhanqi, Zhou Lin.
Spatio-temporal distribution and clustering characteristics of comorbidities among tuberculosis inpatients in Guangdong Province from 2016 to 2024
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 448-458.
|
| [3] |
Liu Xi, Liu Yuze, Hua Weiyu, Li Jie, Zhang Ying, Dong Bin.
Epidemiological characteristics of pulmonary tuberculosis among residents in Haidian District,Beijing from 2012 to 2022 and its correlation with population density
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 459-467.
|
| [4] |
Wang Yongbing, Zhong Yuexiang, Fu Xiuying, Zhang Ying, Weng Wenpei, Zhou Fangjing, Yang Yingzhou, Luo Jilun.
Survey of Mycobacterium tuberculosis infection rate and analysis of associated factors among three priority populations in Yingde’s zero-TB community pilot areas,Guangdong Province
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 468-476.
|
| [5] |
Miao Honghao, Zhang Jie, Pang Mengdi, Ren Yixuan, Deng Yang, Yi Junli, Fan Ruifang, Chen Shuangshuang, Chen Hao, Yu Lan, Li Jie, Li Chuanyou, Yang Xinyu.
Genotypic and drug resistance of Mycobacterium tuberculosis in Beijing,2024
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 477-484.
|
| [6] |
Li Jing, Zhang Yangyi, Yang Jinghui, Wu Zheyuan, Li Ningdi, Yu Chenlei, Wang Lili, Shen Xuhui, Jiang Yuan, Shen Xin.
Study on the characteristics of rpoB gene mutations in Mycobacterium tuberculosis and its correlation with rifampicin resistance level in Shanghai
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 485-494.
|
| [7] |
Zhong Guowei, Zhang Shaoyi, Fan Huiling.
Expression and clinical value of serum LncRNA LINC00707 and miR-382-5p in patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 495-503.
|
| [8] |
Jiang Lina, Dai Wenxi, Ju Hanfang, Meng Sukai, Wang Chunhua.
Clinical value of auramine O fluorescence staining automatic microscopic scanning and recognition system for detecting tuberculosis
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 504-509.
|
| [9] |
Han Yanzhuo, Lu Zhenhui, Su Ben, Zhou Rui, Chen Jiajun, Wu Xianwei, Wu Dingzhong, Zhang Shaoyan, Qiu Lei.
Analysis of the clinical characteristics of post-tuberculosis bronchiectasis
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 510-517.
|
| [10] |
Gao Xianru, Cui Wenjuan, Zhang Mengran, Yang Kefan, Hao Huiyuan, Yang Lu, Sun Wenwen.
Study on the health management journey map of 15 initially treated pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 518-524.
|
| [11] |
Yang Jie, Dong Ning, Wei Xiaowen, Wu Yan, Dong Wenfang, Wu Yuanhao, Zhang Lin.
Effects of family participatory intervention on medication adherence and lung function based on health action process approach in elderly patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 525-533.
|
| [12] |
Du Fangfang, Cao Xuefang, Wang Jin, Jin Qi, Liu Jianjun, Gao Lei, Cheng Shiming.
Analysis of current developing situation of group standards of Chinese Antituberculosis Association
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 534-540.
|
| [13] |
Qiu Yuxian, Huang Fang, Yang Xiaoyi, Yang Feng, Lu Hua, Zhang Tianyi, Zhang Yang, Yao Rong, Li Yuanyuan.
Research progress in digital twin technology for tuberculosis patient management
[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 550-555.
|
| [14] |
Shu Wei, Liu Yuhong.
Interpretation of research and innovation part of the WHO Global Tuberculosis Report 2025
[J]. Chinese Journal of Antituberculosis, 2026, 48(3): 307-312.
|
| [15] |
Wang Jing, Jing Wei, Li Weiwen, Zhu Qingdong, Pang Yu, Chu Naihui, Nie Wenjuan.
Clinical cohort analysis of the efficacy and safety of extended-course bedaquiline in patients with multidrug-resistant/rifampicin-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2026, 48(3): 313-319.
|